Navigation Links
Select in Medical Technology

NHS National Innovation Centre Cites VNUS Closure(R) Procedure as Select Innovative Technology

Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO SAN JOSE, Calif., April 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS ), a worldwide leader in medical devices for the minimally invasive treatment of venous refl...

Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk

CINCINNATI, Jan. 31 /PRNewswire-FirstCall/ -- The Kroger Co. (NYSE: KR ) said today it is recalling peanut butter store-baked and store-packaged cookies and select cakes sold in its family of stores because the products have the potential to be contaminated with Salmonella. Stores under th...

ApoCell's Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy

HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented the results of a study conducted by researchers at the University of Chicago and ApoCell at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago in early June. The study showed that ApoCell's adva...

John Legend and Gap Join (PRODUCT)RED(TM) to Help Eliminate AIDS in Africa with Exclusive (RED)ZONE Seating at Madison Square Garden

...son Square Garden in New York City. Beginning July 29th, every purchase at select Gap stores in the New York tri-state area will include a special access cod...tically receive a second ticket to the show free of charge. Additionally, a select number of fans seated in the (RED)ZONE section will be randomly selected to...

Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window

...al Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL, the data suggests that this treatment is safe and potentially leads to improved outcomes for a select number of late-presenting patients, including those who awake with stroke symptoms. According to lead author Raul Nogueira, M.D., Assistant in ...

Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship

... Providing a framework for identifying and cultivating joint opportunities for philanthropic development; and Identifying approaches to co-brand select clinical programs. Montefiore Medical Center encompasses 125 years of outstanding patient care, innovative medical "firsts," pio...

Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler

...collagen or anesthetic in Artefill. Artefill is only offered by a select group of physicians in Northern California and is not available at all physician offices. Dr. Rosenberg is one of the company trained and select few company sponsored physicians who has the skills and experience needed t...

Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced

...e collection holds considerable potential for product innovation, DANONE RESEARCH using state-of-the-art technologies such as genomics and robotics to select the probiotic bacteria of the future is carefully studying it. For more information, please visit www.danone.com/?lang=en , www.danone.com/en/res...

Music & Medicine: Unique Collaboration Combines Performing Arts and Science

...al Sciences, the School of Public Health, and the School of Health Professions. The center's Institutes for Discovery conduct leading-edge research on select health issues, including vision, aging, cancer, heart disease, physical medicine and public health. This year, the Texas College of Osteopathic Medici...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

...eractions, alcohol-induced dose-dumping, and the methodology used to characterize such interactions. The review found that the combination of EtOH and select opioids at the studied doses does not appear to produce additive pharmacodynamic effects, while the pharmacokinetic profiles may be affected for certa...

Inspiration for 'My Sister's Keeper' Speaks Out

...the new movie starring Cameron Diaz on Friday. With the help of Denver infertility specialist Dr. William B. Schoolcraft, the Nashes were able to select an embryo that met two criteria: it didn't carry the genetic abnormality that would cause Fanconi Anemia (FA), an often-fatal genetic disease, and it ...

CRi Oosight(TM) Instrument Crucial in IVF Breakthrough Demonstrating a Correlation Between Non-Invasive Egg Metrics and Pregnancy

...widely used by embryologists as an aid in the field of in vitro fertilization (IVF), has been used in a groundbreaking study that investigated ways to select eggs most likely to produce a pregnancy. Dr. Suha Kilani, senior scientist at IVF Australia in Sydney, led a group which included researchers fr...

ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease

...ed design of future ecabet sodium studies, the results of future or ongoing studies with ISTA's low-dose formulation of bromfenac, ISTA's intention to select one or more products to advance to Phase 3 in 2010, ISTA's belief that low-dose bromfenac has an effect on the conjunctiva and cornea's dry eye damage...

Single Port Surgeries Now Performed at University Medical Center at Princeton

...d appendix removals make up the vast majority of his single port procedures. The technique is also being used in kidney donation operations and other select procedures. The benefits for patients are substantial. Cosmetically, the single port approach is a major advance as it leaves the patient with ...

Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections

...fficacy of the 200 mg dose in patients is consistent with the dose predictions based on animal efficacy studies. Collectively, these data enable us to select the 200 mg dose for our Phase 3 pivotal trials in complicated skin and soft tissue infections." Torezolid was well tolerated by patients in this ...

IBM and EU Partners Create a Better Way to Fight AIDS Virus

...on of information technology promotes positive social and economic progress. Nominations are evaluated by an independent board of CIO-level judges who select Laureates, Finalists and award recipients, in 10 industry-related categories, to be honored at the Laureate Medal Ceremony. This year's ceremony and a...

Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer

...ip are co-developing PLX4032 for potential use in a number of cancers harbouring the BRAF mutation. They are also co-developing the diagnostic test to select mutation-positive patients for clinical trials, and ultimately, for treatment with PLX4032. "PLX4032 has shown both tumour shrinkage and delay in...

MitraClip(R) Therapy Data Demonstrate Clinical Benefit in High-Risk Patients With Mitral Regurgitation

... trials. "The High Risk Registry data support our belief that the MitraClip therapy is a safe and clinically beneficial treatment alternative for select patients suffering from significant functional or degenerative MR," said Dr. Kar. "Patients otherwise unable to withstand more invasive treatments can...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... TAXUS(R) Element(TM) Stent now available in select markets worldwide NATICK, Mass., May 19 /PRNewswire-FirstCall/ -- Bost...m chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The TAXUS Element Stent features a new platinum chromiu...

Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial

...ived a single injection of either a placebo or the VLP vaccine at doses of 15 mcg or 60 mcg per strain. The results of this study will be used to help select a dose for further evaluation in a clinical trial involving adults 65 years of age and older later this year and in a subsequent Phase III efficacy st...

ADVENTRX Announces Results From ANX-514 Bioequivalence Study

...ncluding the discontinuation of substantially all of its development activities and fundamental business operations and reduction in force to a small, select number of full-time employees, will negatively impact ADVENTRX's ability to consummate a strategic transaction; the potential for regulatory authoriti...

Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients

...we expect to report the first antiviral data in the second half of 2009. In addition, we are collecting preclinical data from our research efforts to select a purine nucleos(t)ide for clinical development." Phase III QUASH Studies The QUASH studies are international, multi-center, randomized, doub...

Unemployment, Health Care Spending Affect Mortality

...f Biomedical Sciences, the School of Public Health, and the School of Health Professions. The Health Science Center conducts leading-edge research on select health issues, including vision, aging, cancer, heart disease, physical medicine and public health. This year, the Texas College of Osteopathic Medi...

Studies Show Combination Laser Therapy Effective At Clearing Acne, Reducing Oil Production

...therapies as a long-term solution for treating active acne. The key is to distinguish the benefits and limitations of these available technologies and select the most effective treatments for each acne patient." Photodynamic Therapy with a Photosensitizer In a preliminary study, Dr. Alexiades-Ar...

CEL-SCI Corporation Releases Letter to Shareholders

...cial downturn. In looking back at the last year, I see a year of meaningful accomplishments which put CEL-SCI in a valuable position, and among a very select group of companies that have a completely novel medicine with blockbuster potential ready to go into a Phase III clinical trial. Key Company hi...

ESBATech's Antibody Fragment Enters Phase Ib/IIa in Ophthalmology

... has successfully screened and characterized the entire human pool (1.5 million) of naturally occurring variable immunoglobulin (VH and VL) domains to select highly stable, soluble and monomeric single-chain antibody fragment frameworks. ESBATech's unique, scientific approach to stabilize monomeric, single-...

ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium

...ed to the anticipated design of future ecabet sodium studies, the results of future or ongoing studies with lower strength Xibrom, ISTA's intention to select one or more products to advance to Phase III in 2010, ISTA's belief that ecabet sodium not only improves the quality of tears but also increases the q...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

...ue dopamine receptor activity should allow a personalized approach to patient treatment for schizophrenia by making it possible for the first time, to select a clinical dose capable of saturating 5HT2A receptors while permitting the "dialing in" of an optimal amount of dopamine receptor modulation by simple...

Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline

...s (in collaboration with GlaxoSmithKline). All of Biotica's projects employ its proprietary technology, polyketide bioengineering, which enables it to select from the many known polyketides with biological activity and make a range of derivatives that are either difficult or impossible to make by medicinal ...

ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity

... has successfully screened and characterized the entire human pool (1.5 million) of naturally occurring variable immunoglobulin (VH and VL) domains to select highly stable, soluble and monomeric single-chain antibody fragment frameworks. ESBATech's unique, scientific approach to stabilize monomeric, single-...

Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2

...r multiple myeloma. The primary endpoints of the oral dose escalating trial are determination of safety, tolerance and PK properties of CX-4945 and to select the appropriate dose for Phase II trials. In addition, multiple mechanism-related pharmacodynamic biomarkers that were validated in preclinical studie...

Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium

...roup by reclassifying them as either 'high' or 'low' risk, making risk prediction more specific, should go a long way in helping medical professionals select the most appropriate therapy for each of their patients." On Saturday, Matthew Goetz, M.D., from Mayo Clinic and colleagues from Austria prese...

Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects

...induced by drugs in cardiovascular and psychiatric medicine. PhyzioType Systems are designed to provide physicians with an unprecedented capability to select for each patient the safest drug treatment to enhance compliance. Genomas is located in Hartford, CT on the campus of Hartford Hospital. www.genoma...

Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives

...stablishing Sangamo's ZFN technology as a new approach for rapid generation of "knock-out" cell lines (Santiago et al., 2008, PNAS 105: 5809). select 2009 Objectives During the briefing Sangamo will also discuss the following objectives for 2009: -- Sangamo expects to file an IND for...

A Window Into Parkinson's Disease

...rch Foundation. Established in 2001 to support and expand the pioneering research of Paul Greengard, Nobel laureate, at The Rockefeller University and select academic research centers in the U.S. Media contact: For information on The Michael Stern Parkinson's Research Foundation, please contact Betsey O...

Tackling Atrial Fibrillation and Associated Cardiovascular Risk

... 1) To obtain your teleconference number, register first by following the instructions above. 2) Once connected, a pop-up window will appear 3) select country of affiliation to obtain local dial-in number 4) Dial-in and enter your login details using the provided number within the pop-up window Pl...

SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.

...A based biotechnology company, emphasizes that the select TRIAL results -- that were announced yesterday -- ... a form of selenium known as selenomethionine. The select TRIAL found no effects of either selenomethionine ... http://www.cypsystems.com . The results of the select TRIAL are consistent with previous animal studies....

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

...s or both cell types defines the co-receptor tropism of the patient virus. Trofile is the only clinically validated tropism assay and has been used to select patients in all phase II and phase III studies of CCR5 antagonists to date. In June 2008, optimization of Trofile made it substantially more sensiti...

Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting

...rature in hospital critical care settings. Controlling body temperature, through cooling and warming, is becoming the standard of care for patients in select critical conditions and those undergoing a variety of surgical procedures. Alsius markets a comprehensive suite of catheter-based intravascular temper...

Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General

...gs, where the need is greatest. Clinical trials for the CD4 system will begin in the 4th quarter of this year and the instrument will be launched to select markets in mid-2009. Inverness plans to feature the product at the 15th Annual Conference on AIDS and STIs (ICASA) in Dakar, Senegal December 3-7, 200...
Other Tags
(Date:9/12/2014)... YORK and POINT ROBERTS, Washington ... Investorideas.com ( http://www.investorideas.com ) a global news source covering ... analysts and experts on the September 9 th launch ... of Goode Intelligence, Janice Kephart , founder of ... Gino Pereira of NXT-ID, Inc, (NASDAQ: NXTD ...
(Date:9/11/2014)... reduced frequency of social interactions and an increased ... has also been linked to dysfunction of the ... Now Caltech researchers have discovered antagonistic neuron populations ... animal engages in social behaviors or asocial repetitive ... neural circuit dysfunctions that underlie autism in humans. ...
(Date:9/11/2014)... DDT, American peregrine falcons ( Falco peregrines anatum ) ... stop rearing young birds in captivity and placing them ... models that year in ESA,s journal Ecological ... in California, with and without direct human intervention in ... would continue to recover without captive rearing, though the ...
Breaking Biology News(10 mins):Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 2Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 3Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 4Biometric Experts Comment on Launch of Apple Pay Smart Wallet Payment Service 5Tipping the balance of behavior 2Tipping the balance of behavior 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 2Volunteer 'eyes on the skies' track peregrine falcon recovery in California 3Volunteer 'eyes on the skies' track peregrine falcon recovery in California 4Volunteer 'eyes on the skies' track peregrine falcon recovery in California 5
(Date:9/13/2014)... Va. (PRWEB) September 13, 2014 Happiness is ... to healthier living and achieving goals. That's what LWell ... pleased to announce that Stephens, a life coach who has ... was a teenager, will present her "Happiness is a Choice" ... 6:30 p.m. , This event is being offered ...
(Date:9/13/2014)... MD (PRWEB) September 13, 2014 Deaf Awareness ... The Hearing and Speech Agency hosts a week-long ... Sign Language (ASL) as the main form of communication. ... the schedule includes an ASL film night, a yoga class, ... open to the entire community. , The schedule is as ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Motion Graphics artist ... new transition pack entitled TransPack Volume 2 exclusively for Final ... fun way to transition from one clip to the next.” ... can never have too many transition options and TransPack Volume ... TransPack Volume 2 is a package of 30 thematic transitions ...
(Date:9/13/2014)... September 13, 2014 Although it’s cooled ... into mosquito high season are the state’s southern cities ... areas. With a rise in mosquitoes carrying West ... a partnership with Dixie State University’s Dr. Barnum and ... a product called NutriVex. , NutriVex is in its ...
(Date:9/12/2014)... As low testosterone lawsuit claims continue ... two of the U.S. Food & Drug Administration (FDA) ... to discuss controversial public health issues surrounding testosterone replacement ... and the Drug Safety and Risk Management Advisory Committee ... population for testosterone replacement therapy and the potential risk ...
Breaking Medicine News(10 mins):Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 2Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 3Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 2Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 3Health News:Today a new TransPack Volume 2 transition was announced from Pixel Film Studios for Final Cut Pro X. 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 3Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 2Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 3Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 4Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 5
Other Contents